Dr Md Nematullah
Assistant Professor
| Department of Pharmacy
Integral University, Lucknow
Uttar Pradesh
Expertise:
Pharmacology and Pharmacy
10
Publications
1
Projects
46
Scopus Citations
30
CrossRef
6 Years 7 Months Total Experience
Scopus
46
Citations
5
h-index
CrossRef
30
Citations
5
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Tools used in Diagnosis of COPD &Asthma
2018
NIMS University
Pharmaceutical Care & Pharmacist Interventions
2019
Pharmacon Society for Pharmacy Practice
Safety of Medicine & Medical Devices
2018
Indian Pharmacopoeia Commission (IPC)
National Conference on Pharmacovigilance
2018
DPSRU University
Research Methodology
2018
Jamia Hamdard University, New Delhi
69 th IPC
2017
Chitkara University, Chandigarh
Emerging Careers in Pharmaceutical Industry (Clinical Research, Pharmacovigilance, and Data Management
2017
IIHMR University
Antimicrobial Stewardship: Improving Clinical Outcomes by Optimization of Antibiotic Practice
2020
Stanford University.
Medicine Grand rounds Novel corona virus
2020
Stanford University. School of Medicine
Introduction to Clinical Research
2020
The Global Health Network.
ICH Good Clinical Practice E6 (R2
2020
The Global Health Network.
Introduction to Pharmacovigilance
2020
Uppsala Monitoring Centre
Community & Membership
Board of Studies
MemberResearch
Research coordinatorTime Table coordinator
CoordinatorNo Data Found
There is currently nothing to display here.
Personal Details
Doctor of Pharmacy
2020
Tumkur University, Tumkur
Assistant Professor
Mar 2023 – Present
Integral University, Lucknow
| Department of Pharmacy
Assistant Professor
Mar 2021 – Mar 2023
Mangalayatan University, Aligarh
| Department of Pharmacy
Research Investigator
Jul 2019 – Jul 2020
Nims University Rajasthan, Jaipur
Medical and Health Sciences
Scholarly Work
To Evaluate the Adverse Effects of Erythropoietin According to CTCAE V4.03 Criteria in Patient Having Anemia with Chronic Kidney Disease
OtherPharmacoeconomic evaluation of telmisartan as monotherapy compared with telmisartan plus HCTZ as a combination therapy in hypertensive patients
No Data Found
There is currently nothing to display here.
Scholarly Publications
Long-Term Safety of Dpp-4 Inhibitors: An Insight from Clinical Trials and Real-World Evidence
Inflammation demystified: An in-depth comprehensive review
Docking study of novel designed indazole derivatives against topoisomerase-II DNA gyrase enzyme for antibacterial screening
Open AccessFrom Pond Scum to Miracle Molecules: Cyanobacterial Compounds New Frontiers
Open AccessSynthesis of 1,3-substituted 1H-indazole derivatives and evaluation of anti-inflammatory activity in Sprague Dawley rats
Open AccessSynthesis and evaluation of antibacterial activity of novel 3-methyl-1H-indazole derivatives
Open AccessGuillain–barré syndrome (GBS) with compressive myelopathy: A case report
Open Access
10.1016/j.ipha.2023.07.004
Crossref: 1
Evaluation of therapeutics' drug monitoring during cancer chemotherapy: A review
Open Access
Showing 1 to 8 of 10 publications